Drug Database
Back to search

Belgium· BE-AMP-SAM289457-00

Savene 20 mg/ml

A dexrazoxane product containing dexrazoxane hydrochloride, registered in Belgium by Cnx Therapeutics Ireland. The same ATC class is registered in 15 of our 19 countries.

ATC V03AF02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedSavene 20 mg/mlATCV03AF02REGISTER NO.BE-AMP-SAM289457-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dexrazoxane hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dexrazoxane is registered in 15 of 19 countries.

Countries holding a registration under ATC V03AF02 (dexrazoxane), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search dexrazoxane products by name

Dexrazoxane · ATC V03AF02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dexrazoxane costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dexrazoxane · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • FI Finland$8.88
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dexrazoxane Hydrochloride
Manufacturer
Cnx Therapeutics Ireland
Country
Belgium (BE)
ATC code
V03AF02
ATC class
Dexrazoxane
Defined daily dose
1.5 g, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0786665
  • be_apb
    2447597

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

8 interactions on record for dexrazoxane.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dexrazoxane against other medicinesHow interaction checks work

Dexrazoxane · interactions on record

8 records

  • 2 severe
  • 6 moderate

Most severe, free to view

  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • Lactobacillus acidophilusJ07AX04moderate
  • DoxorubicinL01DB01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dexrazoxane in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexrazoxane products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Cyrdanax
  • Czechia · Cyrdanax
  • Germany · Cardioxane, Cyrdanax
  • Spain · Cardioxane
  • France · Cardioxane, Cyrdanax
  • United Kingdom (Northern Ireland) · Cardioxane
  • Hungary · Cyrdanax
  • Iceland · Savene
  • Italy · Cardioxane
  • Liechtenstein · Savene
  • Netherlands · Cardioxane
  • Norway · Savene
  • Poland · Cyrdanax
  • Romania · Cyrdanax
  • Slovakia · Cyrdanax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/31014b90-83dd-47f7-9252-6b1bee0fb818
GET /v1/drugs/31014b90-83dd-47f7-9252-6b1bee0fb818?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Savene 20 mg/ml",
  "name_fr": "Savene 20 mg/ml",
  "name_nl": "Savene 20 mg/ml",
  "amp_code": "SAM289457-00",
  "strengths": [
    "20.0000",
    "20.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Dexrazoxane Hydrochloride",
    "Dexrazoxane",
    "Potassium Chloride",
    "Sodium Acetate Trihydrate",
    "Sodium Chloride",
    "Sodium Gluconate",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dexrazoxane",
  "authorisation_numbers": [
    "EU/1/06/350/001"
  ]
}
API referenceMCP serverPlans

See everything about dexrazoxane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console